Phototrichogram as a tool to assess the effectiveness of minoxidil therapy in patients with androgenetic alopecia

Vavilov V.V.

MNPTsDK Departament zdravookhraneniia Moskvy;
Pervyĭ MGMU im. I.M. Sechenova

Tsimbalenko T.V.

Tsentr trihologii Tat'jany Tsimbalenko, Moskva, Rossija, 127055

Kaverina I.V.

Tsentr trihologii Tat'jany Tsimbalenko, Moskva, Rossija, 127055

Phototrichogram as a tool to assess the effectiveness of minoxidil therapy in patients with androgenetic alopecia

Authors:

Vavilov V.V., Tsimbalenko T.V., Kaverina I.V.

More about the authors

Journal: Russian Journal of Clinical Dermatology and Venereology. 2016;15(6): 56‑65

DOI: 10.17116/klinderma201615656-65

Downloaded: 103

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Vavilov VV, Tsimbalenko TV, Kaverina IV. Phototrichogram as a tool to assess the effectiveness of minoxidil therapy in patients with androgenetic alopecia. Russian Journal of Clinical Dermatology and Venereology. 2016;15(6):56‑65. (In Russ.)
https://doi.org/10.17116/klinderma201615656-65

Close metadata

Recommended articles:

Minoxidil-induced ophthalmic hypertension (case report). Russian Annals of Ophthalmology. 2024;(2-2):90-93

Androgenetic alopecia (AGA) is the genetically determined androgen-induced chronic miniaturization of follicles in the parietal region. The phototrichogram technique is the main diagnostic tool identifying morphometric changes in hair typical of AGA that is used most commonly in trichological practice. Today, topical forms of minoxidil remain the primary pharmacological treatment for androgenetic alopecia. Research results have shown high efficacy of this pharmaceutical in increasing hair thickness at the frontoparietal region. However, in most of these studies, only some of the diagnostically relevant criteria of phototrichogram were taken into account. The study analyzed the dynamics of phototrichogram indexes during therapy with 5% minoxidil foam, as well as their relationship with the quality of life of patients.

Keywords:

androgenetic alopecia

hair follicle cycle

phototrichogram

minoxidil

foam as a dosage form

Authors:

Vavilov V.V.

MNPTsDK Departament zdravookhraneniia Moskvy;
Pervyĭ MGMU im. I.M. Sechenova

Tsimbalenko T.V.

Tsentr trihologii Tat'jany Tsimbalenko, Moskva, Rossija, 127055

Kaverina I.V.

Tsentr trihologii Tat'jany Tsimbalenko, Moskva, Rossija, 127055

List of references:

Blumeyer A, Tosti A, Messenger A, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. J Dtsch Dermatol Ges. 2011 Oct;9 Suppl 6:S1–57.
Alsantali A, Shapiro J. Androgens and hair loss. Curr Opin Endocrinol Diabetes Obes. 2009 Jun. 16(3):246-253.
Shapiro J. Clinical practice: Hair loss in women. N. Engl. J. Med. 357(16), 1620–1630(2007).
Rudnicka L, Olszewska M, Rakowska A, Kowalska-Oledzka E, Slowinska M. Trichoscopy: A new method for diagnosing hair loss. J Drugs Dermatol. 2008;7:651–654.
Rakowska A, Slowinska M, Kowalska-Oledzka E, Olszewska M, Rudnicka L. Dermoscopy in female androgenic alopecia: Method standardization and diagnostic criteria. Int J Trichology. 2009;1:123–130.
Hillmann K, Garcia Bartels N, Kottner J et al. A single centre, ran- domised, double-blind, placebo-controlled clinical trial to investigate efficacy and safety of minoxidil topical foam in frontotemporal and vertex androgenetic alopecia in men. Skin Pharmacol Physiol 2015; 28: 236–244.
Olsen EA, Dunlap FE, Funicella T et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol 2002; 47: 377-385.
Olsen EA, Whiting D, Bergfeld W, et al. A multicenter, randomized, placebocontrolled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2007 Nov;57(5):767–774.
Blume-Peytavi U, Hillmann K, Dietz E, et al. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women. J Am Acad Dermatol. 2011 Dec;65(6):1126–1134 e2.
Han JH1, Kwon OS, Chung JH, Cho KH, Eun HC, Kim KH. Effect of minoxidil on proliferation and apoptosis in dermal papilla cells of human hair follicle. J Dermatol Sci. 2004 Apr;34(2):91-98.
Rudnicka L, Olszewska M, Rakowska A, Slowinska M. Trichoscopy update 2011. J Dermatol Case Rep. 2011;5:82–88.
D D’Amico, M Vaccaro, F Guarneri, F Borgia, S Cannavo, B Guarneri. Phototrichogram using videomicroscopy: a useful technique in the evaluation of scalp hair. Eur. J. Dermatol. 11, 17 (2001)
Hoffmann R, Lüdtke H, Hoffman-Wecker M, Hughes-Formella BJ Digital imaging for measuring of hair growth on the human scalp In: E Berardesca et al. (eds); Non Invasive Diagnostic Techniques in Clinical Dermatology (2014), Page 413-422
Van Neste D, Trüeb RM. Critical study of hair growth analysis with computer-assisted methods. JEADV (2006) 20, 578–583
Torres F, Tosti A. Trichoscopy: an update. G Ital Dermatol Venereol. 2014;149:83-91.
Kanti V, Hillmann K, Kottner J, Stroux A, Canfield D, Blume-Peytavi U. Effect of minoxidil topical foam on frontotemporal and vertex androgenetic alopecia in men: a 104-week open-label clinical trial. J Eur Acad Dermatol Venereol. 2016 Jul;30(7):1183-1189. doi: 10.1111/jdv.13324. Epub 2015 Sep 21.

Close metadata